What's on?

From 24 to 30 April: World Vaccination Week

21 Apr 2017 | By INSERM (Newsroom) | International



On the initiative of WHO, World Vaccination Week is the opportunity to raise public awareness of the vital importance of vaccination throughout life.

The number of children in the world who are not vaccinated or are inadequately vaccinated is 19.4 million, according to WHO.

In France, the latest data from the Institute of Health Monitoring (InVS) indicate that in children, there is vaccination coverage of 91% against diphtheria, tetanus, polio and whooping cough. With regard to vaccination coverage of Measles, Mumps, Rubella (MMR), it is only 72% in children of 24 months.

To understand the individual and collective challenges of vaccination, in partnership with Muscadier publications, Inserm has published an educational manual explaining the function of vaccines, their role and their benefits but also their limits:

Vaccination: Agression or Protection? “, in the Choc Santé collection, edited by Annick Guimenazes, an Inserm researcher at the Marseille-Luminy Centre of Immunology (CIML) and Marion Mathieu, Doctor of Biology and engineer at ESPCI-ParisTech.

The recent occurrence of epidemics and pandemics – the Ebola epidemic in West Africa and that of Zika in the Americas, have highlighted the urgency of developing vaccines, by creating innovative partnerships between the different participants in global vaccine research.

For Yves Lévy, Chairman and CEO of Inserm: “The Ebola epidemic proved that we can develop vaccines quickly in extremely difficult conditions. It also proved that one of the keys to success is the willingness of all those involved to work hand in hand.”

Inserm, the National Institutes of Health (NIH) in the United States and the London School of Hygiene & Tropical Medicine, LSHTM, in collaboration with the health authorities of Guinea and Liberia, have launched a new clinical trial on the Ebola vaccine candidates, under the aegis of the PREVAC (Partnership for Research on Ebola VACcination) international consortium. 

Read the report “Ebola: a new clinical trial launched in West Africa to assess three vaccination strategies” published on 6 April in the Inserm Press Room.

See also the vaccination file on the Inserm site.

Researcher Contact

Annick Guimezanes
Co-auteure du livre Choc Santé “Vaccination, agression ou protection”
Immunologiste, ancienne chercheuse Inserm
06 77 97 95 75

Odile Launay
Coordinatrice du réseau national de recherche clinique en vaccinologie
Centre d’investigation clinique en vaccinologie
CIC Cochin Pasteur
01 58 41 28 60

Brigitte Autran
Unité 1135 Centre d’immunologie et de maladies infectieuses
Chef du Pôle Biologie Médicale et Pathologie et du Département d’Immunologie
Hôpital Pitié-Salpêtrière
01 42 17 74 03

CoReVac – Consortium national de Recherche sur les Vaccins

Yazdan Yazdanpanah
Directeur de l’ITMO Immunologie, inflammation, infectiologie et microbiologie
Investigateur principal de l’étude PREVAC
06 12 14 21 56